Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of metabolic syndrome in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T. Arai H, et al. Among authors: sasaki j. J Atheroscler Thromb. 2006 Aug;13(4):202-8. doi: 10.5551/jat.13.202. J Atheroscler Thromb. 2006. PMID: 16908953 Free article.
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults.
Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, Sasaki J; Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Hata Y, et al. Among authors: sasaki j. J Atheroscler Thromb. 2002;9(1):1-27. doi: 10.5551/jat.9.1. J Atheroscler Thromb. 2002. PMID: 12238634 Free article.
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.
Yamamoto A, Arakawa K, Sasaki J, Matsuzawa Y, Takemura K, Tsushima M, Fujinami T, Mabuchi H, Itakura H, Yamada N, Toyota T, Oikawa S; Rosuvastatin Dose-Ranging Trialist Group. Yamamoto A, et al. Among authors: sasaki j. J Atheroscler Thromb. 2002;9(1):48-56. doi: 10.5551/jat.9.48. J Atheroscler Thromb. 2002. PMID: 12238638 Free article. Clinical Trial.
Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Horiuchi H, et al. Among authors: sasaki j. J Am Geriatr Soc. 2004 Dec;52(12):1981-7. doi: 10.1111/j.1532-5415.2004.52552.x. J Am Geriatr Soc. 2004. PMID: 15571531
Serum lipid survey and its recent trend in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T. Arai H, et al. Among authors: sasaki j. J Atheroscler Thromb. 2005;12(2):98-106. doi: 10.5551/jat.12.98. J Atheroscler Thromb. 2005. PMID: 15942120 Free article.
Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T, Hattori H, Shirahashi N, Kita T. Arai H, et al. Among authors: sasaki j. J Atheroscler Thromb. 2005;12(5):240-50. doi: 10.5551/jat.12.240. J Atheroscler Thromb. 2005. PMID: 16205020 Free article.
The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.
Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Itakura H; J-LIT Study Group. Shimamoto K, et al. Among authors: sasaki j. Hypertens Res. 2005 Nov;28(11):879-87. doi: 10.1291/hypres.28.879. Hypertens Res. 2005. PMID: 16555576 Clinical Trial.
Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Oikawa S, et al. Among authors: sasaki j. Atherosclerosis. 2007 Apr;191(2):440-6. doi: 10.1016/j.atherosclerosis.2006.04.017. Epub 2006 Jun 12. Atherosclerosis. 2007. PMID: 16765358
Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T, Hattori H, Kita T. Arai H, et al. Among authors: sasaki j. J Atheroscler Thromb. 2007 Aug;14(4):167-71. doi: 10.5551/jat.e499. Epub 2007 Aug 14. J Atheroscler Thromb. 2007. PMID: 17704619 Free article.
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; JELIS Investigators, Japan. Saito Y, et al. Among authors: sasaki j. Atherosclerosis. 2008 Sep;200(1):135-40. doi: 10.1016/j.atherosclerosis.2008.06.003. Epub 2008 Jun 19. Atherosclerosis. 2008. PMID: 18667204 Clinical Trial.
1,568 results